Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Customers Bancorp, Inc | 334 | Sep 20, 2024 | 44.00 | +0.46 |
Cutera, Inc. | TJ9 | Sep 20, 2024 | 0.67 | +0.03 |
CVB Financial Corporation | BCV | Sep 20, 2024 | 16.40 | +0.61 |
CVC CAPITAL PARTNERS PLC | Z1W | Sep 20, 2024 | 19.77 | -1.49 |
CVD Equipment Corporation | 0V3 | Sep 20, 2024 | 2.84 | +0.71 |
CVR Energy Inc | FL9 | Sep 20, 2024 | 21.10 | -1.40 |
CVS Group Plc | 4C9 | Sep 20, 2024 | 14.00 | -1.41 |
CVS HEALTH CDR(REG.S) | CVS0 | Sep 20, 2024 | 9.10 | -1.09 |
CVS Health Corporation | CVS | Sep 20, 2024 | 52.27 | +0.06 |
CVW CLEANTECH INC. | TMD0 | Sep 20, 2024 | 0.58 | +0.87 |
CY4GATE S.P.A. | 68H | Sep 20, 2024 | 4.92 | -1.01 |
Cyan AG | CYR | Sep 20, 2024 | 2.12 | -4.50 |
CyanConnode Holdings Plc | CUAN | Sep 20, 2024 | 0.13 | +58.75 |
Cyber Security 1 | 7CS | Sep 20, 2024 | 0.01 | -3.70 |
CyberAgent,Inc. | CL2 | Sep 20, 2024 | 6.60 | +0.76 |
CyberArk Software Ltd. - Ordinary Shares | CYB | Sep 20, 2024 | 241.20 | -0.82 |
CyberCatch Global | D0K | Sep 20, 2024 | 0.12 | 0.00 |
Cyberdyne Inc | 8C4 | Sep 20, 2024 | 1.21 | -4.57 |
CYBEROO S.P.A. | K97 | Sep 20, 2024 | 2.77 | -3.48 |
CYBERTRUST JAPAN | 5U2 | Sep 20, 2024 | 12.50 | 0.00 |
Cybin Inc | R7E1 | Sep 20, 2024 | 6.22 | 0.00 |
Cyfrowy Polsat SA | CP9 | Sep 20, 2024 | 3.05 | -0.84 |
Cymbria Corp | CYOA | Sep 20, 2024 | 47.40 | -0.42 |
CYNATA THERAPEUTICS LTD Ordinary Shares(Australia) | 51S | Sep 20, 2024 | 0.12 | +40.11 |
Cytokinetics, Incorporated | KK3A | Sep 20, 2024 | 48.40 | -3.20 |
Cytomed Therapeutics | F98 | Sep 20, 2024 | 1.34 | -1.47 |
CytomX Therapeutics, Inc. | 6C1 | Sep 20, 2024 | 1.01 | -1.95 |
Cytosorbents Corporation | HQE1 | Sep 20, 2024 | 1.24 | -0.96 |
Cyviz | 8P9 | Sep 20, 2024 | 2.69 | +3.46 |
Cyxone | 4CX | Sep 20, 2024 | 0.00 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.